In Vivo Dynamic of Amyloid Induced Dystrophic Neurites
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
A2004240
Summary
In AD, the appearance of dystrophic or degenerating neuritis, which are thought to disrupt neuronal function, correlates with the clinical severity of dementia. However, it remains unknown whether the damage to these neuronal structures is static, dynamic or possibly reversible. Dr. Brendza is analyzing neuritic plaques in the brains of living transgenic mice that develop amyloid plaques and AD-like pathology. Amyloid-associated dystrophic neurites, as well as unaffected neuron structures, can be visualized in these animals by their inherent fluorescence. Dr. Brendza is using this system to investigate whether dystrophic neurites undergo dynamic changes over time and to determine if treatments that remove amyloid will reverse the neuronal damage. It is hoped that this research will yield new insight into the dynamic nature of amyloid toxicity and help scientists understand whether removing existing amyloid or sequestering diffusible toxic forms of amyloid-beta peptide is a valid target for the treatment of Alzheimer’s disease.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University